Fig. 3From: Cardiac and noncardiac biomarkers in patients undergoing anthracycline chemotherapy – a prospective analysisFold change (increase or decrease) in biomarker levels (A) from Pre-Chemo to End-Chemo, (B) from Pre-Chemo to Post-Chemo. The horizontal line represents the median and interquartile ranges of the fold changes in biomarkers. **p < 0.001; *0.01 ≤ p < 0.05Back to article page